Metavivor Research and Support

About Metavivor Research and Support

Metavivor Research and Support Inc centers its grantmaking on stage IV metastatic breast cancer, with research awards that reach from exploratory work to translational and clinical studies. In 2025, its largest listed grant was $900,000 to University of California San Francisco for research, a signal that the foundation supports substantial multi-year or high-intensity projects alongside its standard award programs. The recent grants also show repeated support for major cancer and medical research institutions, including Memorial Sloan Kettering Cancer Center and Johns Hopkins Univeristy, as well as university-based programs across the country. The foundation’s work is tied to metastatic breast cancer research, but it also includes patient-centered priorities such as quality of life and side effects of treatment. Its active programs include early career investigator support, exploratory awards, translational research, and a quality of life research award. METAvivor also supports advocacy and peer-to-peer community building, linking research funding to the needs of people living with metastatic breast cancer and caregivers. The pattern is specialized rather than broad: nearly all listed grants are research awards, and the foundation uses competitive grant programs to fund that work.

What Metavivor Research and Support Funds

Metavivor Research and Support Inc funds several distinct strands of metastatic breast cancer work. In translational research, it gave $450,000 to Lab Central for research, showing support for early phase basic and translational studies aimed at moving discoveries toward patient care. For clinical and biomarker-oriented work, the foundation awarded $450,000 to New York University Grossman School of Medicine for research, matching its stated interest in diagnosis, treatment, and barriers to progress in metastatic breast cancer. The foundation also backs exploratory work. A $650,000 grant to University of Texas reflects support for research at a large scale, while the active exploratory award program is designed for one-year pilot or feasibility studies. Patient-centered research appears in the newer quality of life track: METAvivor’s active Quality of Life Research Award is meant for studies on side effects and quality of life issues for people living with metastatic breast cancer.

How Metavivor Research and Support Gives